LifeStance Health Group, Inc. (LFST) News
Follow LifeStance Health Group, Inc. (LFST) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 13 public stories across 8 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
LFST: National leader drives growth with tech, specialty services, and margin expansion
Outpatient mental health remains fragmented, but the organization leads with a national footprint and strong clinician growth. Productivity and revenue gains are driven by AI, operational improvements, and expanding spec
NEWS | Sep 15, 2026, 03:42 PM UTC
L
LFST: Double-digit growth, tech-driven productivity, and specialty services fuel expansion and margin gains
Outpatient mental health remains fragmented, but the organization leads with 8,500 clinicians and 600 centers, driving double-digit growth and productivity gains through AI and operational improvements. Specialty service
NEWS | Sep 15, 2026, 03:06 PM UTC
L
LifeStance Health Group agrees to repurchase 2.0M shares; 22.25M shares sold by insiders
LifeStance Health Group entered an underwriting agreement for an underwritten offering of 22,250,000 shares and repurchased 2,000,000 of those shares from the underwriter.Key Highlights:Original SEC Filing: LifeStance He
REGULATION | Sep 11, 2026, 08:34 PM UTC
L
Barclays maintains LifeStance Health at Overweight
EQUITY | Sep 10, 2026, 01:23 PM UTC
L
LifeStance Health prices secondary public offering
LifeStance Health Group announced the pricing of a secondary public offering.
EQUITY | Sep 09, 2026, 01:21 PM UTC
L
LifeStance Health Group files secondary offering of 22.25M shares
Content provided by Seeking Alpha is intended for information purposes only, and that Seeking Alpha does not offer any personalist investment advice and is not a licensed securities dealer, broker, US investment adviser
EQUITY | Sep 09, 2026, 12:21 PM UTC
M
LifeStance Health launches secondary public offering
LifeStance Health Group announced the launch of a secondary public offering.
EQUITY | Sep 09, 2026, 11:02 AM UTC
L
LifeStance CTO sold $541K of shares at $12.87 average
Officer Paunovich Vukasin, Chief Technology Officer, reported selling LifeStance Health Group common stock on 2026-09-02. The weighted average selling price was $12.87 per share for 42,067 shares, totaling $541,402.
EQUITY | Sep 04, 2026, 09:01 PM UTC
L
LifeStance management to present at upcoming investor conferences
LifeStance Health Group said management will present at upcoming investor conferences, including the 2026 Jefferies Healthcare Services conference. Further conference details were not included in the provided text.
EQUITY | Sep 01, 2026, 08:17 PM UTC
L
LFST - LifeStance to Present at Upcoming Investor Conferences
LFST - LifeStance to Present at Upcoming Investor Conferences
EQUITY | Sep 01, 2026, 08:10 PM UTC
L
LifeStance Health Gr Raises FY2026 Sales Guidance from $1.640B-$1.680B to $1.685B-$1.725B vs $1.665B Est
LifeStance Health Gr (NASDAQ: LFST ) raises FY2026 sales outlook from $1.640 billion-$1.680 billion to $1.685 billion-$1.725 billion vs $1.665 billion estimate.
EARNINGS | Aug 06, 2026, 10:15 AM UTC
L
LFST - LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook
LFST - LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook
EARNINGS | Aug 06, 2026, 10:00 AM UTC
L
LFST Reiterate Overweight, continue to like the setup ahead of Q2 but appreciate short term risk of PE overhang given recent surge in shares
LFST Reiterate Overweight, continue to like the setup ahead of Q2 but appreciate short term risk of PE overhang given recent surge in shares @ BARC
EQUITY | Jul 14, 2026, 11:46 AM UTC